Get the Stockscreener App
0.099
0.90%
-0.0009
LEE PHARMACEUTICALS Stock (LPHM) Forecast
The LEE PHARMACEUTICALS (LPHM) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.2848, representing a +187.68% increase from the current price of $0.099. The highest analyst price target is $0.3823, and the lowest is $0.1874.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month LPHM Price Target
Average 1.0258
(+936.14% Upside)
Long-term LPHM price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about LEE PHARMACEUTICALS financial reports and earnings history, LEE PHARMACEUTICALS (LPHM) stock could reach $2.0495 by 2030, $4.4994 by 2040 and $5.9991 by 2050. See the projected annual prices until 2050 of the LEE PHARMACEUTICALS stock below:
- LEE PHARMACEUTICALS (LPHM) is expected to reach an average price of $2.4573 in 2035, with a high prediction of $3.3131 and a low estimate of $2.4573. This indicates an $2,382% rise from the last recorded price of $0.099.
- LEE PHARMACEUTICALS (LPHM) stock is projected to chart a bullish course in 2040, with an average price target of $3.1106, representing an $3,042% surge from its current level. The forecast ranges from a conservative $3.1106 to a sky-high $4.4994.
- Our analysts predict LEE PHARMACEUTICALS (LPHM) to jump 3,496% by 2045, soaring from $3.5608 to an average price of $3.56, potentially reaching $5.3715. While $3.5608 is the low estimate, the potential upside is significant.
- LEE PHARMACEUTICALS (LPHM) stock is expected to climb by 2050, reaching an average of $4.3625, a $4,307% jump from its current level. However, a wide range of estimates exists, with high and low targets of $5.9991 and $4.3633, respectively, highlighting the market's uncertainty.
LEE PHARMACEUTICALS Stock (LPHM) Year by Year Forecast
LEE PHARMACEUTICALS Stock (LPHM) Price Forecast for 2026
The predicted value for LEE PHARMACEUTICALS (LPHM) in 2026 is set at an average of $0.9287. Estimates vary from a peak of $1.6926 to a trough of $0.1649, indicating an +838.12% surge from the present price of $0.099.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2026 | $0.2848 | $0.1874 | $0.3823 | +187.68% |
| June, 2026 | $1.2161 | $1.2966 | $1.521 | +1,128% |
| July, 2026 | $1.063 | $1.0681 | $1.1361 | +973.78% |
| August, 2026 | $0.754 | $0.754 | $0.9656 | +661.63% |
| September, 2026 | $0.3518 | $0.3598 | $0.6458 | +255.35% |
| October, 2026 | $1.6163 | $0.2098 | $1.6926 | +1,533% |
| November, 2026 | $1.2828 | $1.3559 | $1.5149 | +1,196% |
| December, 2026 | $1.0023 | $1.0023 | $1.2126 | +912.42% |
LEE PHARMACEUTICALS Stock (LPHM) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for LEE PHARMACEUTICALS (LPHM) is $1.2199, with a high forecast of $2.2074 and a low forecast of $0.2323. This indicates an +1,132% increase from the last price of $0.099.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.659 | $0.6598 | $0.883 | +565.63% |
| February, 2027 | $0.3187 | $0.3187 | $0.5634 | +221.87% |
| March, 2027 | $1.5927 | $0.2323 | $1.8642 | +1,509% |
| April, 2027 | $1.2361 | $1.3198 | $1.495 | +1,149% |
| May, 2027 | $0.9972 | $1.003 | $1.1675 | +907.31% |
| June, 2027 | $0.5203 | $0.5303 | $0.9061 | +425.60% |
| July, 2027 | $2.0432 | $0.2548 | $2.0358 | +1,964% |
| August, 2027 | $1.5476 | $1.6207 | $1.9188 | +1,463% |
| September, 2027 | $1.2876 | $1.2926 | $1.4616 | +1,201% |
| October, 2027 | $0.8842 | $0.8842 | $1.1812 | +793.18% |
| November, 2027 | $0.3793 | $0.3793 | $0.7824 | +283.15% |
| December, 2027 | $1.9836 | $0.2773 | $2.2074 | +1,904% |
LEE PHARMACEUTICALS Stock (LPHM) Price Forecast for 2028
In 2028, LEE PHARMACEUTICALS (LPHM) is projected to reach an average price of $1.4252, with a high projection of $2.5506 and a low estimate of $0.2998. This indicates an +1,340% rise from the last price of $0.099.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.6131 | $1.6521 | $1.8828 | +1,529% |
| February, 2028 | $1.1678 | $1.1736 | $1.4662 | +1,080% |
| March, 2028 | $0.7343 | $0.7343 | $1.0609 | +641.69% |
| April, 2028 | $0.4561 | $0.2998 | $0.6124 | +360.69% |
| May, 2028 | $1.9171 | $1.9976 | $2.379 | +1,836% |
| June, 2028 | $1.6071 | $1.6122 | $1.7979 | +1,523% |
| July, 2028 | $1.1411 | $1.1411 | $1.4704 | +1,053% |
| August, 2028 | $0.5427 | $0.5507 | $0.9937 | +448.18% |
| September, 2028 | $2.435 | $0.3223 | $2.5506 | +2,360% |
| October, 2028 | $1.8622 | $1.9012 | $2.2945 | +1,781% |
| November, 2028 | $1.4679 | $1.4679 | $1.6995 | +1,383% |
| December, 2028 | $0.9676 | $0.9684 | $1.3093 | +877.37% |
LEE PHARMACEUTICALS Stock (LPHM) Price Forecast for 2029
The 2029 price forecast for LEE PHARMACEUTICALS Stock (LPHM) is $1.7051 on average, with a high prediction of $3.0654 and a low estimate of $0.3447. This represents an +1,622% increase from the previous price of $0.099.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.5888 | $0.3447 | $0.8328 | +494.73% |
| February, 2029 | $2.3329 | $2.3986 | $2.7222 | +2,257% |
| March, 2029 | $1.8195 | $1.9032 | $2.196 | +1,738% |
| April, 2029 | $1.4236 | $1.4294 | $1.6808 | +1,338% |
| May, 2029 | $0.7505 | $0.7605 | $1.2932 | +658.06% |
| June, 2029 | $2.9012 | $0.3672 | $2.8938 | +2,831% |
| July, 2029 | $2.2094 | $2.2825 | $2.7375 | +2,132% |
| August, 2029 | $1.7924 | $1.7974 | $2.0842 | +1,710% |
| September, 2029 | $1.2321 | $1.2321 | $1.6468 | +1,145% |
| October, 2029 | $0.531 | $0.531 | $1.091 | +436.34% |
| November, 2029 | $2.7632 | $0.3897 | $3.0654 | +2,691% |
| December, 2029 | $2.2357 | $2.2747 | $2.6231 | +2,158% |
LEE PHARMACEUTICALS Stock (LPHM) Price Forecast for 2030
LEE PHARMACEUTICALS Stock (LPHM) is expected to reach an average price of $1.9104 in 2030, with a high forecast of $3.4086 and a low forecast of $0.4122. This signifies an +1,830% surge from the last price of $0.099.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.5941 | $1.5999 | $2.0495 | +1,510% |
| February, 2030 | $1.0037 | $1.0037 | $1.448 | +913.79% |
| March, 2030 | $0.6274 | $0.4122 | $0.8425 | +533.70% |
| April, 2030 | $2.6181 | $2.6986 | $3.237 | +2,545% |
| May, 2030 | $2.1512 | $2.1563 | $2.4597 | +2,073% |
| June, 2030 | $1.5282 | $1.5282 | $1.9752 | +1,444% |
| July, 2030 | $0.7336 | $0.7416 | $1.3416 | +641.01% |
| August, 2030 | $3.2538 | $0.4347 | $3.4086 | +3,187% |
| September, 2030 | $2.6064 | $2.6795 | $3.074 | +2,533% |
| October, 2030 | $1.9335 | $1.9335 | $2.4577 | +1,853% |
| November, 2030 | $1.2762 | $1.277 | $1.7357 | +1,189% |
| December, 2030 | $0.7797 | $0.4572 | $1.1022 | +687.56% |
0.27%
0.34%
Cap:
|
Volume (24h):